search
Back to results

SMS Messaging for Invitation in the Cervical Cancer Screening Programme (CERCA-SMS)

Primary Purpose

Cervical Cancer, Human Papilloma Virus

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
SMS invitation
Phone call invitation
Sponsored by
Institut Català d'Oncologia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cervical Cancer focused on measuring Screening, Self-sampling

Eligibility Criteria

35 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Eligible women for cervical cancer screening aged 30 to 65 years of age.
  • Registered at the Health Care Database (RCA).

Exclusion Criteria:

  • Individuals without a mobile phone number registered at the RCA.

Sites / Locations

  • Institut Català d'OncologiaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental - Intervention

Active Comparator - Usual Care

Arm Description

SMS invitation to participate in cervical cancer screening using HPV self-sampling.

Phone call invitation to participate in cervical cancer screening using HPV self-sampling.

Outcomes

Primary Outcome Measures

Participation in cervical cancer screening program
Participation (no/yes) in cervical cancer screening program will be gathered prospectively 12 weeks after sending the screening invitation (day 0).

Secondary Outcome Measures

Full Information

First Posted
May 2, 2022
Last Updated
May 2, 2022
Sponsor
Institut Català d'Oncologia
search

1. Study Identification

Unique Protocol Identification Number
NCT05362669
Brief Title
SMS Messaging for Invitation in the Cervical Cancer Screening Programme
Acronym
CERCA-SMS
Official Title
SMS Messaging for Invitation in the HPV-based Cervical Cancer Screening Programme in Catalonia (CERCA-SMS Study)
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 8, 2021 (Actual)
Primary Completion Date
May 31, 2022 (Anticipated)
Study Completion Date
December 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Català d'Oncologia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A study on two different methods of invitation to participate to the cervical cancer screening programme will be conducted within a demonstration project to switch from cytology-based screening to HPV-based screening using self-sampling delivered through the network of pharmacy offices among regular screening attendants in the Barcelona Metropolitana Sud Area, in Catalonia. At the moment, eligible women are invited to participate to cervical cancer screening via a telephone call invitation explaining the new self-sampling method. Invitation via SMS containing a link to a webpage with information on most frequent questions might be an adequate alternative method that would save costs and workload on human resources. The aim of this study is to assess the impact on cervical cancer screening participation of an invitation method based on text messaging (SMS). The invitation method will be evaluated through an interventional trial, in which we will compare the invitation to cervical cancer screening using SMS versus a telephone call invitation explaining the new self-sampling method.
Detailed Description
Main Hypothesis: The use of direct SMS without an explanatory call for cervical cancer screening invitation is an acceptable option to invite women if the participation obtained is more than 70% and not less than 15% of the call (current practice). Specific Hypothesis: Participation in cervical cancer screening programme using SMS invitation is non-inferior to 70%. Participation in cervical cancer screening programme using telephone call is non-inferior to 70%. Participation using SMS invitation is non-inferior to participation using telephone call invitation, considering that an absolute difference less than 15% may not be clinically relevant. Sample size calculation: A one-sample non-inferiority test for calculating sample size was performed, assuming a participation rate of 80% using SMS invitation and 85% using telephone call invitation in the cervical cancer screening programme. To detect a participation rate using SMS or telephone call invitation non-inferior to 70%, with a margin of 5%, accepting an alpha risk of 0.025 and a beta risk of 0.2, and 5% of loses of follow-up, we will need 27 women in the telephone call group and 59 women in the SMS group. To observe this non-inferiority by age group (≤40 years, 41-54 years, ≥55 years), 27 and 59 women will be needed for each age group. To compare both study arms, a two-sample non-inferiority test was performed assuming that using SMS messages to invite women to participate in cervical cancer screening programme will be 5% lower compared to participation when invitation is performed by a phone call (80% versus 85% respectively), although this difference will be non-inferior to 15-15.5%. Thus, if there is a true difference in favor of the telephone call group of 5%, assuming 5% of loses of follow-up, then 450 women will be required (225 in each arm) to be 80% sure that the upper limit of a one-sided 97.5% confidence interval will exclude a difference in favor of the SMS group of more than 15-15.5%. Randomization procedure: Women will be randomized in two study arms: intervention (SMS message invitation) and control (telephone call invitation). Randomization will be performed based on permuted blocks of 6 women to ensure equal distribution among age groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Cancer, Human Papilloma Virus
Keywords
Screening, Self-sampling

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Invitation to cervical cancer screening using SMS compared to telephone call invitation.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
450 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental - Intervention
Arm Type
Experimental
Arm Description
SMS invitation to participate in cervical cancer screening using HPV self-sampling.
Arm Title
Active Comparator - Usual Care
Arm Type
Active Comparator
Arm Description
Phone call invitation to participate in cervical cancer screening using HPV self-sampling.
Intervention Type
Behavioral
Intervention Name(s)
SMS invitation
Intervention Description
Behavioral: SMS to invite to cervical cancer screening using HPV self-sampling.
Intervention Type
Behavioral
Intervention Name(s)
Phone call invitation
Intervention Description
Behavioral: Phone call to invite to cervical cancer screening using HPV self-sampling.
Primary Outcome Measure Information:
Title
Participation in cervical cancer screening program
Description
Participation (no/yes) in cervical cancer screening program will be gathered prospectively 12 weeks after sending the screening invitation (day 0).
Time Frame
12 weeks

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Only women participate in cervical cancer screening programme
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Eligible women for cervical cancer screening aged 30 to 65 years of age. Registered at the Health Care Database (RCA). Exclusion Criteria: Individuals without a mobile phone number registered at the RCA.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Paula Peremiquel-Trillas, MD, MPH, PhDc
Phone
+34932607812
Ext
3118
Email
paula.peremiquel@iconcologia.net
First Name & Middle Initial & Last Name or Official Title & Degree
Esther Roura Fornells, MPH, PhD
Phone
+34932607812
Ext
3185
Email
eroura@iconcologia.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paula Peremiquel-Trillas, MD, MPH, PhDc
Organizational Affiliation
Institut Català d'Oncologia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut Català d'Oncologia
City
L'Hospitalet de Llobregat
State/Province
Catalunya, Spain
ZIP/Postal Code
08908
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paula Peremiquel-Trillas, MD MPH PhDc
Phone
+34932607812
Ext
3118
Email
paula.peremiquel@iconcologia.net
First Name & Middle Initial & Last Name & Degree
Esther Roura Fornells, MPH PhD
Phone
+34932607812
Ext
3185
Email
eroura@iconcologia.net
First Name & Middle Initial & Last Name & Degree
Paula Peremiquel-Trillas, MD, MPH, PhDc
First Name & Middle Initial & Last Name & Degree
Esther Roura Fornells, MPH, PhD
First Name & Middle Initial & Last Name & Degree
Laia Bruni Coccoz, MD, MPH, PhD
First Name & Middle Initial & Last Name & Degree
Clàudia Robles Hellín, MPH, PhD
First Name & Middle Initial & Last Name & Degree
Raquel Ibáñez, MPH, PhD
First Name & Middle Initial & Last Name & Degree
Laura Monfil, BSc
First Name & Middle Initial & Last Name & Degree
Maite Carvajal, RN
First Name & Middle Initial & Last Name & Degree
Rebeca Font

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

SMS Messaging for Invitation in the Cervical Cancer Screening Programme

We'll reach out to this number within 24 hrs